CONTENT
1: Phase II designs for anticancer botanicals and supplements.
Vickers AJ.
J Soc Integr Oncol. 2009 Winter;7(1):35-40.
2: Basic introduction to research: how not to do research.
Vickers AJ.
J Soc Integr Oncol. 2008 Spring;6(2):82-5. Review.
3: Living proof and the pseudoscience of alternative cancer treatments.
Vickers AJ, Cassileth BR.
J Soc Integr Oncol. 2008 Winter;6(1):37-40. Review.
4: Which botanicals or other unconventional anticancer agents should we take to clinical trial?
Vickers AJ.
J Soc Integr Oncol. 2007 Summer;5(3):125-9. Review.
5: Integrative Oncology Practice Guidelines.
Deng GE, Cassileth BR, Cohen L, Gubili J, Johnstone PA, Kumar N, Vickers A; Society for Integrative Oncology Executive Committee, Abrams D, Rosenthal D, Sagar S, Tripathy D.
J Soc Integr Oncol. 2007 Spring;5(2):65-84. Review.
6: How to improve accrual to clinical trials of symptom control 2: design issues.
Vickers AJ.
J Soc Integr Oncol. 2007 Spring;5(2):61-4.
7: How to improve accrual to clinical trials of symptom control 1: recruitment strategies.
Vickers AJ.
J Soc Integr Oncol. 2007 Winter;5(1):38-42.
8: How to randomize.
Vickers AJ.
J Soc Integr Oncol. 2006 Fall;4(4):194-8. Review.
9: How to design a phase I trial of an anticancer botanical.
Vickers AJ.
J Soc Integr Oncol. 2006 Winter;4(1):46-51. Review.
10: Multiple assessment in quality of life trials: how many questionnaires? How often should they be given?
Vickers AJ.
J Soc Integr Oncol. 2006 Summer;4(3):135-8.
11: Acupuncture: integration into cancer care.
Deng G, Vickers A, Simon Yeung K, Cassileth BR.
J Soc Integr Oncol. 2006 Spring;4(2):86-92. Review.
12: How to measure quality of life in integrative oncology research.
Vickers AJ.
J Soc Integr Oncol. 2006 Spring;4(2):100-3.



